- Home
- SNSE vs SEED Comparison
SNSE vs SEED Comparison
Compare SNSE & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNSE | SEED |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 12.6M |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SNSE | SEED |
|---|---|---|
| Price | $33.38 | $1.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $65.00 | N/A |
| AVG Volume (30 Days) | 76.3K | ★ 158.4K |
| Earning Date | 05-05-2026 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.26 | $0.82 |
| 52 Week High | $36.76 | $2.49 |
Technical Indicators
Market Signals| Indicator | SNSE | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 60.91 | 50.06 |
| Support Level | $7.94 | $0.96 |
| Resistance Level | $35.88 | $1.32 |
| Average True Range (ATR) | 3.92 | 0.13 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 90.51 | 32.00 |
Price Performance
Historical ComparisonAbout SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.